Ultrasound in practice
Two algorithms propose when ultrasound evaluation may aid diagnosis in patients at risk of rheumatoid arthritis (RA) or suspected RA and in patients who fulfil the American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteria.
Algorithm 1: Diagnosis
US evaluation in patients at risk of RA or suspected RA
Algorithm 2: Diagnosis
US evaluation in patients who fulfil ACR/EULAR criteria
Algorithms that guide ultrasound evaluation of therapeutic response in RA patients. One algorithm is for assessment of patients starting on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or biological disease-modifying antirheumatic drugs (bDMARDs); one algorithm is for assessment of patients with loss of treatment response.
Algorithm 3: Therapeutic response
US evaluation of therapeutic response in RA patients starting
csDMARDs or bDMARDs
Algorithm 4: Loss of response
US evaluation in RA patients with loss of treatment response
Algorithm showing ultrasound evaluation in assessing remission or low disease activity in rheumatoid arthritis patients.
Algorithm 5: Low disease activity/remission
US evaluation in assessing remission or low disease activity in RA patients
© TUI 2020
Please log in to access the Ambassador area of the website.
Not yet registered? TUI Ambassadors can contact us to request access.